{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T10:14:32Z","timestamp":1787998472952,"version":"build-2784847793"},"reference-count":0,"publisher":"Wiley","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Pharmacology &amp; Therapeutics"],"published-print":{"date-parts":[[2004,4]]},"DOI":"10.1016\/j.clpt.2003.12.005","type":"journal-article","created":{"date-parts":[[2004,4,3]],"date-time":"2004-04-03T10:19:28Z","timestamp":1080987568000},"page":"331-341","source":"Crossref","is-referenced-by-count":97,"title":["Fluvoxamine drastically increases concentrations and effects of tizanidine: a potentially hazardous interaction*1"],"prefix":"10.1111","volume":"75","author":[{"given":"M","family":"GRANFORS","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:27:15Z","timestamp":1699363635000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1016\/j.clpt.2003.12.005"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,4]]},"references-count":0,"aliases":["10.1016\/s0009-9236(03)00747-1"],"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,4]]}},"alternative-id":["S0009-9236(03)00747-1"],"URL":"https:\/\/doi.org\/10.1016\/j.clpt.2003.12.005","relation":{},"ISSN":["0009-9236"],"issn-type":[{"value":"0009-9236","type":"print"}],"subject":[],"published":{"date-parts":[[2004,4]]}}}